𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧’𝐬 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐮𝐭𝐮𝐫𝐞

Citi Pharma and China’s Xin Weisheng are establishing a fully automated antibiotic plant by 2026, producing key APIs and lifesaving antibiotics.
This step reduces import reliance and supports PPMA’s vision of self-reliance and affordable, quality medicines in Pakistan.